GLPcompareGLPcompare
DrugsPricesCompareShortagesEvidenceSupplementsWatchlist
HomeDrug classesAmylin/GLP-1
Drug class

The Amylin/GLP-1 class

Amylin/GLP-1 medications, with sourced prices, shortage reports and study results.

Last checked · Oct 3, 2026 UTC
0approved
2in development

No FDA-approved GLP-1 in this category yet

The medications below are in late-stage development for it.

Investigational (pipeline)

Alphabetical by active ingredient. These entries are not FDA-approved for this category; open a record for the studied uses and evidence.

Amylin/GLP-1Phase 3

Amycretin

Amycretin (investigational)

Subcutaneous injection and oral tablet (both in development) · Once weekly (injectable); once daily (oral)

Investigational. No FDA-approved purchase option.

Study evidence & development
Amylin/GLP-1FDA review

CagriSema

Other classes
GLP-14GIP/GLP-12Small-molecule GLP-12GLP-1/glucagon3GIPR antagonist/GLP-11Triple agonist1All GLP-1 drugs
Browse
IndicationsManufacturers
GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.
GLPcompareGLPcompare

The live, fully-cited reference for the GLP-1 ecosystem. Every figure traces to its source. Informational only, not medical advice.

Product

  • Drugs
  • Prices
  • Compare
  • Shortages
  • Evidence
  • Supplements

Legal

  • Methodology
  • About
  • News
  • Price updates
  • Privacy Policy
  • Terms of Service
  • Support

Some outbound links on GLPcompare are referral links. If you sign up or buy through one, we may earn a commission at no extra cost to you. It never changes the price you pay or the underlying data. Partner status and commission rates contribute to offer and provider value scores and can change their order. Every partner is labeled. Value scores are not medical recommendations; a higher-ranked offer is not necessarily the lowest price or the right product for you.

© 2026 GLPcompare. All rights reserved.

Fazier

CagriSema (investigational)

Subcutaneous injection · Once weekly

Investigational. No FDA-approved purchase option.

Study evidence & development
Compare head-to-head